共 50 条
- [31] Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301)BMC Cancer, 21Keisuke MiwaEiji OkiMasanobu EnomotoKeisuke IharaKoji AndoFumihiko FujitaMasahiro TominagaShinichiro MoriGoro NakayamaMototsugu ShimokawaHiroshi SaekiHideo BabaMasaki MoriYoshito Akagi
- [32] Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301)BMC CANCER, 2021, 21 (01)Miwa, KeisukeOki, EijiEnomoto, MasanobuIhara, KeisukeAndo, KojiFujita, FumihikoTominaga, MasahiroMori, ShinichiroNakayama, GoroShimokawa, MototsuguSaeki, HiroshiBaba, HideoMori, MasakiAkagi, Yoshito
- [33] Neoadjuvant multidisciplinary phase II study (BRANCH) of an early bevacizumab schedule plus chemoradiation therapy in rectal cancer: efficacy, safety, and biomarkers.CANCER RESEARCH, 2012, 72Avallone, AntonioDi Gennaro, ElenaDelrio, PaoloAloj, LuigiTatangelo, FabianaPecori, BiagioLeone, AlessandraCaraco, CorradinaMoccia, TaniaIaffaioli, Vincenzo R.Romano, GiovanniLastoria, SecondoBudillon, Alfredo
- [34] Efficacy and Safety of Neoadjuvant Intensity-Modulated Radiotherapy With Concurrent Capecitabine for Locally Advanced Rectal CancerDISEASES OF THE COLON & RECTUM, 2015, 58 (02) : 186 - 192Wang, LinLi, Zi-YuLi, Zhong-WuLi, Yong-HengSun, Ying-ShiJi, Jia-FuGu, JinCai, Yong
- [35] Phase II study for the evaluation of efficacy of pembrolizumabBJU INTERNATIONAL, 2016, 118 : 28 - 29Naing, AungPant, ShubhamFu, SiqingColen, RivkaPainter, JeaneMcquinn, LaceyMendoza, TitoHess, KennethMeric-Bernstam, FundaTannir, Nizar
- [36] A phase 2 safety and efficacy study of neoadjuvant/adjuvant darovasertib for localized ocular melanomaJOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Joshua, Anthony M.O'day, RoderickGlasson, WilliamSia, DavidMcGrath, LindsayAmeratunga, MalakaCosman, RashaCherepanoff, SvetlanaO'Quigley, MichaelBeaupre, Darrin M.Conway, MaxLim, Li-AnneMcKenzie, JohnMcKay, DanielShackleton, Mark J.Fung, AdrianIsaacs, TimothyYousif, JacobBrooks, ChristinePsaroulis, Trifon
- [37] Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: Results of a phase II studyACTA ONCOLOGICA, 2011, 50 (08) : 1151 - 1157Caravatta, LucianaPadula, Gilbert D. A.Picardi, VincenzoMacchia, GabriellaDeodato, FrancescoMassaccesi, MariangelaSofo, LuigiPacelli, FabioRotondi, FabioCecere, GiuseppeSallustio, GiuseppinaDi Lullo, LiberatoPiscopo, AdeleMignogna, SamanthaBonomo, PierluigiCellini, NumaValentini, VincenzoMorganti, Alessio G.
- [38] Concurrent radiotherapy with capecitabine and weekly irinotecan as neoadjuvant treatment for locally advanced rectal cancer: a phase I/II studyANNALS OF ONCOLOGY, 2004, 15 : 80 - 80Klautke, GuntherFeyerherd, PeterLudwig, KajaFoitzik, ThomasKlar, ErnstFietkau, Rainer
- [39] A phase II open label, single arm study to evaluate the efficacy of pembrolizumab for leukoplakia.JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)Porter, AshleighZeh, Audrey J.Ly, ThuSerna, AlyssaVillanueva, ArturoChai-Ho, WanxingMessadi, DianaMaie, St. JohnWang, MarileneAbemayor, EliotCohen, Ezra E. W.Wong, Deborah J. L.
- [40] The efficacy and safety of short-course radiotherapy followed by sequential chemotherapy and Cadonilimab for locally advanced rectal cancer: a protocol of a phase II studyBMC CANCER, 2024, 24 (01)Xu, TongzhenFeng, LinglingZhang, WenjueLi, HaoyueMa, HuiyingAbulimiti, MuyashaTan, YutongDeng, FeiyanHuang, WentingZou, ShuangmeiKang, WenyanJiang, LimingWang, YingHu, ChenChen, YinggangZhou, HaitaoTang, YuanJin, Jing